SAN DIEGO, April 11, 2023 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced that Kristin Yarema, Ph.D., has joined the Company as President, Cell Therapy effective today. “Kristin brings…Read More
Poseida Therapeutics Appoints Kristin Yarema PhD as President Cell Therapy MarketScreener
